Credit Agricole’s AMAG Pharmaceuticals AMAG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-67,100
Closed -$1.24M 1237
2017
Q3
$1.24M Hold
67,100
﹤0.01% 1052
2017
Q2
$1.24M Sell
67,100
-10,800
-14% -$214K ﹤0.01% 1070
2017
Q1
$1.76M Buy
+77,900
New +$1.87M 0.01% 1037
2016
Q1
Sell
-9,150
Closed -$276K 1414
2015
Q4
$276K Buy
9,150
+450
+5% +$14.5K ﹤0.01% 1252
2015
Q3
$346K Buy
+8,700
New +$540K ﹤0.01% 1222

Other funds holding AMAG

Credit Agricole's AMAG Position: Q4 2017 in Review

Credit Agricole sold out of AMAG Pharmaceuticals (AMAG) in Q4 2017, closing a stake of 67,100 shares — an estimated $1.24M sold.

Credit Agricole first reported a position in AMAG in Q3 2015 and held it in 5 quarters. The position peaked at $1.76M in Q1 2017. 170 funds tracked by Wall St. Rank hold AMAG as of Q4 2017.

  • Credit Agricole reported no remaining AMAG Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Credit Agricole sold 67,100 AMAG Pharmaceuticals shares in Q4 2017, an estimated $1.24M.
  • Credit Agricole first reported a position in AMAG Pharmaceuticals in Q3 2015 and held it in 5 quarters.
  • Credit Agricole's AMAG Pharmaceuticals position peaked at $1.76M in Q1 2017.
  • 170 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2017.

Based on Credit Agricole's 13F filing for Q4 2017, filed 13 Feb 2018.